Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Jingwu_Zang
|
| gptkbp:country |
gptkb:China
|
| gptkbp:focus |
immuno-oncology
autoimmune diseases |
| gptkbp:founded |
2014
|
| gptkbp:headquarters_location |
gptkb:Shanghai
|
| https://www.w3.org/2000/01/rdf-schema#label |
I-Mab
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
gptkb:felzartamab
gptkb:lemzoparlimab uliledlimab |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:IMAB
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.i-mabbiopharma.com/
|
| gptkbp:bfsParent |
gptkb:CBC_Group
gptkb:WuXi_Biologics |
| gptkbp:bfsLayer |
7
|